IgE and chemotherapy

Cancer Immunology, Immunotherapy

Volumn 61, Issue 9, 2012, Pages 1585-1590

  Bluth, Martin H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AllergoOncology Symposium in Writing; Allergy; Antibody; Cancer; Chemotherapy; IgE

Indexed keywords

ADRENALIN; ALKYLATING AGENT; ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CARBOPLATIN; CETUXIMAB; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GLUCAGON; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN E; METHOTREXATE; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; PALONOSETRON; PROCARBAZINE; SYNBIOTIC AGENT; TAMOXIFEN; TEMOZOLOMIDE;

ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; BRONCHOSPASM; CANCER CHEMOTHERAPY; CANCER PATIENT; COLORECTAL CANCER; CONFERENCE PAPER; DESENSITIZATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DYSPNEA; GLIOMA; HEAD AND NECK CANCER; HEALTH CARE COST; HEART ARREST; HORMONAL THERAPY; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; IMMUNOGLOBULIN BLOOD LEVEL; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; NONHUMAN; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; SKIN DISEASE;

ANTINEOPLASTIC AGENTS; DRUG HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E;

EID: 84866541507     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1170-8     Document Type: Conference Paper

References (60)

1. McLaughlan P, Stanworth DR (1975) A critical search for evidence of changes in levels of circulating IgE in patients with cancer. Lancet 1:64-65
2. Merrill RM, Isakson RT, Beck RE (2007) The association between allergies and cancer: what is currently known? Ann Allergy Asthma Immunol 99:102-116
3. Eppel A, Cotterchio M, Gallinger S (2007) Allergies are associated with reduced pancreas cancer risk: a population-based case-control study in Ontario, Canada. Int J Cancer 121:2241-2245 (Pubitemid 47585604)
4. Turner MC, Chen Y, Krewski D, Ghadirian P (2006) An overview of the association between allergy and cancer. Int J Cancer 118:3124-3132
5. Gandini S, Lowenfels AB, Jaffee EM, Armstrong TD, Maisonneuve P (2005) Allergies and the risk of pancreatic cancer: a meta-analysis with review of epidemiology and biological mechanisms. Cancer Epidemiol Biomarkers Prev 14:1908-1916 (Pubitemid 41161199)
6. Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N, Walldius G, Lambe M, Jungner I, Holmberg L (2010) Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control 21:1657-1667
7. Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T, McMillan A, Miike R, Barger G, Wrensch M (2004) Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res 64:8468-8473 (Pubitemid 39491789)
8. Toren K, Palmqvist M, Lowhagen O, Balder B, Tunsater A (2006) Self-reported asthma was biased in relation to disease severity while reported year of asthma onset was accurate. J Clin Epidemiol 59:90-93 (Pubitemid 41797480)
9. Karagiannis SN, Wang Q, East N, Burke F, Riffard S, Bracher MG, Thompson RG, Durham SR, Schwartz LB, Balkwill FR, Gould HJ (2003) Activity of human monocytes in IgE antibodydependent surveillance, killing of ovarian tumor cells. Eur J Immunol 33:1030-1040 (Pubitemid 36546691)
10. Karagiannis SN, Bracher MG, Hunt J, McCloskey N, Beavil RL, Beavil AJ, Fear DJ, Thompson RG, East N, Burke F, Moore RJ, Dombrowicz DD, Balkwill FR, Gould HJ (2007) IgE-antibodydependent immunotherapy of solid tumors: cytotoxic and phagocytic mechanisms of eradication of ovarian cancer cells. J Immunol 179:2832-2843
11. Matta GM, Battaglio S, Dibello C, Napoli P, Baldi C, Ciccone G, Coscia M, Boccadoro M, Massaia M (2007) Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma. Clin Cancer Res 13:5348-5354 (Pubitemid 47510359)
12. Tsavaris N, Tsigalacis D, Kosmas C, Koufos C, Vaiopoulos G, Tzivras M, Kouraklis G, Papadimas V, Georgoulis V, Archimandritis A, Sechas M (1998) Preliminary evaluation of the potential prognostic value of serum levels of immunoglobulins (IgA, IgM, IgG, IgE) in patients with gastric cancer. Int J Biol Markers 13:87-91 (Pubitemid 28488173)
13. Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH (2008) Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 153:401-409
14. Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR, ParsaAT, Sison JD, PradosMD(2006) SerumIgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res 66:4531-4541
15. Kim R, Emi M, Tanabe K, Arihiro K (2006) Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res 66:5527-5536 (Pubitemid 43927099)
16. Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, Schwartzbaum J, Heimberger A, Sampson JH, Chang S, Prados M, Wiencke JK, Wrensch M (2009) IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer 125:680-687
17. Su YC, Rolph MS, Cooley MA, Sewell WA (2006) Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease. J Allergy Clin Immunol 117:635-641 (Pubitemid 43340229)
18. Akasaki M, Ishizaka K (1987) Effects of cyclophosphamide treatment and gamma irradiation of SJL mice on the IgE antibody response and the nature of IgE-binding factors. Int Arch Allergy Appl Immunol 82:417-418 (Pubitemid 17056108)
19. Turk JL, Parker D, Cameron AE (1984) The effect of cyclophosphamide on immunological control mechanisms. Int J Tissue React 6:205-211 (Pubitemid 14030264)
20. Amarante-Mendes JG, Ferreira AP, Macedo MS (1991) Suppression of antibody response to an unrelated antigen in experimental murine paracoccidioidomycosis: effect of cyclophosphamide and indomethacin. J Investig Allergol Clin Immunol 1:185-193
21. Jones RD, Offutt DM, Longmoor (2000) Capture ELISA and flow cytometry methods for toxicologic assessment following immunization and cyclophosphamide challenges in beagles. Toxicol Lett 115:33-44 (Pubitemid 30417453)
22. Graziano F, Haley C, Gundersen L, Askenase PW (1981) IgE antibody production in guinea pigs treated with cyclophosphamide. J Immunol 127:1067-1070 (Pubitemid 11051159)
23. de Macedo MS, Mota I (1982) Antigenic competition in IgE antibody production. II. Effect of cyclophosphamide. Immunology 47:67-74 (Pubitemid 12015204)
24. Pan DY, Qiao JG, Chen JW, Huo YC, Zhou YK, Shi HA (2003) Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial. Hepatobiliary Pancreat Dis Int 2:211-215
25. Davies N, Kynaston H, Yates J, Taylor BA, Jenkins SA (1995) Octreotide, the reticuloendothelial system, and experimental liver tumour. Gut 36:610-614
26. Babina M, Kirn F, Hoser D, Ernst D, Rohde W, Zuberbier T, Worm M (2010) Tamoxifen counteracts the allergic immune response and improves allergen-induced dermatitis in mice. Clin Exp Allergy 40:1256-1265
27. Ishizaka K (1984) Regulation of IgE synthesis. Ann Rev Immunol 2:159-182
28. Ferrazzi M, De Rinaldis ML, Salotti A, Cirelli A (1993) Serum IgE levels in human immunodeficiency virus (HIV)-1 infected patients: correlation between IgE and CD4 ? T cells. Riv Eur Sci Med Farmacol 15:67-70 (Pubitemid 24081133)
29. Tamir R, Barchat I, Weiss H, Pick AI (1993) IgE response in multiple myeloma. Ann Allergy 70:214-217 (Pubitemid 23085935)
30. Bluth MH, Beleza P, Hajee F, Jose-Jordao M, Figueiredo J, Almeida F, Smith-Norowitz TA (2007) IgE mediated hypersensitivity after ibuprofen administration. Ann Clin Lab Sci 37:362-365 (Pubitemid 350105938)
31. Cornejo-Garcia JA, Blanca-López N, Doña I, Andreu I, Agúndez JA, Carballo M, Blanca M, Canto MG (2009) Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab 10:971-980
32. Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, Demoly P, Bousquet PJ, Merk HF, Sanz ML, Ott H, Atanasković- Marković M (2009) Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 64:183-193
33. Mertes PM, Aimone-Gastin I, Guéant-Rodriguez RM, Mouton-Faivre C, Audibert G, O'Brien J, Frendt D, Brezeanu M, Bouaziz H, Guéant JL (2008) Hypersensitivity reactions to neuromuscular blocking agents. Curr Pharm Des 14:2809-2825
34. Mariotte D, Dupont B, Gervais R, Galais MP, Laroche D, Tranchant A, Comby E, Bouhier-Leporrier K, Reimund JM, Le Mauff B (2011) Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis. MAbs 3:396-401
35. Vogel WH (2010) Infusion reactions: diagnosis, assessment, and management. Clin J Oncol Nurs 14:E10-E21
36. Pietkiewicz JM (2011) Possible anaphylaxis to palonoestron. J Oncol Pharm Pract. 22 Aug [Epub ahead of print]
37. Dorris K, Fouladi M, Davies SM, Perentesis JP, Lawrence JM, Chow LM, Assa'ad A, Uygungil B, Jodele S (2011) Severe allergic reactions to thiol-based cytoprotective agents Mesna and Amifostine in a child with a supratentorial primitive neuroectodermal tumor. J Pediatr Hematol Oncol 33:e250-e252
38. Pugi A, Benemei S, Vietri M, Tondo A, Calvani AM, Mugelli A, Vannacci A, Lapi F (2011) Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review. J Clin Pharm Ther. May doi:10.1111/j.1365- 2710.2011.01275.x [Epub ahead of print]
39. Bautista MA, Stevens WT, Chen CS, Curtis BR, Aster RH, Hsueh CT (2010) Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature. J Hematol Oncol 3:12
40. Lee C, Gianos M, Klaustermeyer WB (2009) Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents. Ann Allergy Asthma Immunol 102:179-187
41. Syrigou E, Dannos I, Kotteas E, Makrilia N, Tourkantonis I, Dilana K, Gkiozos I, Saif MW, Syrigos KN (2011) Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol. Int Arch Allergy Immunol 156:320-324
42. Castells M (2006) Rapid desensitization of hypersensitivity reactions to chemotherapy agents. Curr Drug Saf 1:243-251
43. Joly F, Ray-Coquard I, Fabbro M, Donoghoe M, Boman K, Sugimoto A, Vaughan M, Reinthaller A, Vergote I, Ferrandina G, Dell'anna T, Huober J, Pujade-Lauraine E (2011) Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial. Gynecol Oncol 122:226-232
44. Fotiadis CI, Stoidis CN, Spyropoulos BG, Zografos ED (2008) Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer. World J Gastroenterol 14:6453-6457
45. Dennis T, Fanous M, Mousa S (2009) Natural products for chemopreventive and adjunctive therapy in oncologic disease. Nutr Cancer 61:587-597
46. Iannitti T, Palmieri B (2010) Therapeutical use of probiotic formulations in clinical practice. Clin Nutr 29:701-725
47. Yoshida A, Aoki R, Kimoto-Nira H, Kobayashi M, Kawasumi T, Mizumachi K, Suzuki C (2011) Oral administration of live Lactococcus lactis C59 suppresses IgE antibody production in ovalbumin-sensitized mice via the regulation of interleukin-4 production. FEMS Immunol Med Microbiol 61:315-322
48. Segawa S, Nakakita Y, Takata Y, Wakita Y, Kaneko T, Kaneda H, Watari J, Yasui H (2008) Effect of oral administration of heatkilled Lactobacillus brevis SBC8803 on total and ovalbuminspecific immunoglobulin E production through the improvement of Th1/Th2 balance. Int J Food Microbiol 121:1-10 (Pubitemid 350266890)
49. Gourbeyre P, Denery S, Bodinier M (2011) Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions. J Leukoc Biol 89:685-695
50. Kaplan JL, Shi HN, Walker WA (2011) The role of microbes in developmental immunologic programming. Pediatr Res 69:465-472
51. Rook GA, Dalgleish A (2011) Infection, immunoregulation, and cancer. Immunol Rev 240:141-159
52. Juliá-Serdá G, Cabrera-Navarro P, Acosta-Fernández O, Martín-Pérez P, Losada-Cabrera P, García-Bello MA, Carrillo-Díaz T, Antó-Boqué J (2011) High prevalence of asthma and atopy in the Canary Islands, Spain. Int J Tuberc Lung Dis 15:536-541
53. Davies MG (1978) Serum IgE, lymphomas, and atopy. Br Med J 1:580-581
54. Biggar RJ, Christiansen M, Rostgaard K, Smedby KE, Adami HO, Glimelius B, Hjalgrim H, Melbye M (2009) Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma. Int J Cancer 124:2616-2620
55. Kural YB, Su O, Onsun N, Uras AR (2010) Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma. Int J Dermatol 49:390-395
56. DiGiuseppe JA, Borowitz MJ (1998) Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 25:6-10 (Pubitemid 28090906)
57. Pangalis GA, Angelopoulou MK, Vassilakopoulos TP, Siakantaris MP, Kittas C (1999) B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders. Semin Hematol 36:104-114 (Pubitemid 29214064)
58. Foley KA, Wang PF, Barber BL, Long SR, Bagalman JE, Wagner V, Song X, Zhao Z (2010) Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab. Ann Oncol 21:1455-1461
59. Overbeek JA, Zhao Z, van Herk-Sukel MP, Barber BL, Gao S, Herings RM (2011) Costs of hospital events in patients with metastatic colorectal cancer. J Med Econ 14:656-661
60. George TJ Jr, Laplant KD, Walden EO, Davis AB, Riggs CE, Close JL, George SN, Lynch JW (2010) Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment. J Support Oncol 8:72-77